Newsroom

FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the Compensation Committee of KalVista’s Board of Directors granted five newly-hired employees inducement options to purchase an aggregate of 66,375 shares of KalVista common stock on April 1, 2026 as inducements material to each employee entering into employment with KalVista. The options have an exercise price that is equal to the closing price of KalVista common stock...

ANAHEIM, Calif.--(BUSINESS WIRE)--EACO Corporation (OTCID:EACO) announced the results for its quarter ended February 28, 2026. Net sales, net income and earnings per share were as follows for the quarter ended February 28, 2026 (dollars in thousands, except per share information):   Three Months Ended February 28, %   2026 2025 Change   (unaudited) (unaudited)       Net sales $117,836 $100,132 17.7%         Net income $9,797 $6,763 44.9%         Basic earnings per common share $2.01 $1.39 44.6%...

STUART, Fla.--(BUSINESS WIRE)--Seacoast Banking Corporation of Florida (NASDAQ: SBCF), a bank holding company whose operating entity is Seacoast Bank, today announced it will release first quarter 2026 results on April 28th, after the market closes. Upon release, investors may access a copy of Seacoast’s earnings results at the company’s website www.SeacoastBanking.com on the home page by selecting “Press Releases” under the heading “News/Events.” Seacoast will host a conference call April 29th...

ST. GEORGE, Utah--(BUSINESS WIRE)--SkyWest, Inc. (NASDAQ: SKYW) will host a live conference call and webcast after the market closes on Thursday, April 23, 2026 to discuss first quarter 2026 results. The format will include an overview of the quarterly results followed by a Q&A session. Thursday, April 23, 2026 2:30 p.m. Mountain Time Interested parties can access the webcast at: https://events.q4inc.com/attendee/179256265 The call-in number for US callers is 1-888-330-2455 The call-in numb...

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on April 1, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock options to purchase an aggregate of 188,500 shares of common stock to thirteen new employees under the Company’s 2024 In...

HILLSBORO, Ore.--(BUSINESS WIRE)--Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced it was named a multi-award winner at the 2026 Cybersecurity Excellence Awards for its security leadership. The Lattice MachXO5™-NX TDQ FPGA family was recognized in the Post-Quantum Cryptography (PQC) category for being the industry’s first FPGA family to deliver CNSA-2.0 compliant PQC, crypto agility, and a hardware Root of Trust. In addition, the Lattice Cyber Resilience...

STATE COLLEGE, Pa.--(BUSINESS WIRE)--Kish Bancorp, Inc. (OTCQX: KISB) (“Kish” or the “Company”), parent company of Kish Bank, today announced that its Board of Directors declared a quarterly cash dividend of $0.40 per share on April 1, 2026. The dividend will be payable April 30, 2026, to shareholders of record on April 15, 2026. This dividend per share is unchanged from the previous quarter. About Kish Bancorp, Inc. Kish Bancorp, Inc. is a diversified financial services corporation headquarter...

GEORGE TOWN, Cayman Islands--(BUSINESS WIRE)--Leading offshore law firm Baker & Partners is pleased to announce the appointment of Natascha Steiner-Smith as Partner. Natascha’s arrival further reinforces the firm’s reputation in the Cayman Islands for independent, conflict-free advice and advocacy in complex, cross-border disputes, and marks another significant step in its growth story in the Caribbean. Natascha joins Partners Jennifer Colegate, Fleur O’Driscoll and Robert Jones in the Caym...

BOSTON--(BUSINESS WIRE)--SV Health Investors (“SVHI”), a healthcare and life sciences focused private investment firm, announced today the acquisition of EpiVax, Inc. Headquartered in Providence, RI, EpiVax is a leading bioanalytical CRO specializing in immunogenicity risk assessments for pharmaceutical and biotech companies. EpiVax has been a pioneer in pre-clinical drug development for over 25 years, serving as a trusted scientific advisor to life sciences clients. EpiVax represents a new pla...

DENVER, N.C.--(BUSINESS WIRE)--Unox sponsors FEED26, the FCSI Educational Foundation's invite-only design workshop, investing in the next generation of foodservice professionals....